Token merging module. حسب Wen-Qing Huang (5258126)

Comparative results of the ablation experiments. حسب Wen-Qing Huang (5258126)

Key safety measures including adverse events. حسب Anuja Dokras (8679261)

"…At the end of the study, the prevalence of MetS was 26.2% (17/65) in the metformin group, 28.6% (17/59) in the Combined group, and 28.8% (17/59) in COCP group with no significant difference in trend of MetS prevalence between groups (adjusted <i>p</i> = 0.26). …"

Demographics of the study population. حسب Sohyun Park (78358)

Table 3 - حسب Sohyun Park (78358)

Imformation. حسب Shicheng Luo (14349225)

Data. حسب Su Hwan Park (15158181)

Findings of the study. حسب Kalaivanan Syasyila (21430046)

PRISMA Flowchart. حسب Kalaivanan Syasyila (21430046)

General description of the study. حسب Kalaivanan Syasyila (21430046)

Quality Assessment. حسب Kalaivanan Syasyila (21430046)

Inclusion and exclusion criteria. حسب Kalaivanan Syasyila (21430046)

European study sites. حسب Graeme T. Swindles (7192745)

Location of study sites. حسب Graeme T. Swindles (7192745)

Baseline characteristics of patients. حسب Su Hwan Park (15158181)

Primers for quantitative real-time PCR. حسب Ya-nan Hu (12508990)

Changes in best-corrected visual acuity and total area reduction ratio of the epiretinal membrane (ERM) during follow-up. حسب Su Hwan Park (15158181)

End-systolic pressure–volume loop relationship slope during CPR. حسب Woo Jin Jung (3279570)

Factors associated with the <i>SS</i> Positives. حسب Anuradha Rajamanickam (5278013)

RV PV loop eccentricity during CPR. حسب Woo Jin Jung (3279570)